Crystallization technologies are bridges between drug substances (DS) and drug products (DP) enabling consistent and robust safety and efficacy profiles of small molecule based medicines. In an effort to fully utilize existing tools and develop better new method-logies for solving bottleneck problems in drug develop-ment, the Center for Pharma Crystallization (CfPC) at J-STAR Research launched its first annual conference, jointly with XtalPi.
